Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Colfax Corporation    CFX


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

DJO :® Revolutionizes the Orthopedic Journey with the Launch of Motion iQ™

08/06/2020 | 04:46pm EST

A digital patient relationship management tool that seamlessly connects clinicians and patients across the orthopedic care continuum

DJO, LLC (“DJO” or the “Company”), a leading global provider of medical technologies to get and keep people moving, introduces Motion iQ™, an innovative new software solution designed to transform the surgical journey by connecting the surgeon, care team and patient throughout the continuum of care.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200806005329/en/

DJO Motion iQ Patient Engagement Platform (Graphic: Business Wire)

DJO Motion iQ Patient Engagement Platform (Graphic: Business Wire)

As a leader in orthopedics from preventive care and surgical intervention to post-operative rehab, DJO® is committed to helping enhance patient outcomes and optimizing overall costs for orthopedic patients and providers. Motion iQ will help “hold that patient’s hand” through the entire episode of care with personalized messaging and customized home recovery exercises along with supportive content to reinforce and amplify the voice and guidance of the surgical team.

“We are committed to providing patients and surgeons with the meaningful tools to enhance the surgical experience,” said Brady Shirley, CEO of DJO®. “The Motion iQ platform transforms the surgeon, practice, and patient experience through an industry-leading digital health solution, and we are proud to launch the first-ever platform that can provide real-time data and tracking to both the patient and care team.”

Motion iQ helps empower patients to take an active role in their care through a more personalized and informed surgical journey, while providing the care team with continuous health and activity data.

How does it work? Patients download a simple, user-friendly app that allows them to send text and video messages as well as images to the care team and access personalized information, physical therapy exercises, and other resources. Motion iQ helps enable the care team to remotely track and monitor patient progress, allows patients and surgeons to communicate via direct messaging, and helps promote compliance through personalized patient education. A provider dashboard tracks patient data and provides progress reports, flagging patients who are not meeting recovery benchmarks or may need clinical interventions.

“As a collaborator in the development of DJO’s Motion iQ platform, I am confident that Motion iQ delivers more value for surgeons, surgical support teams and patients than any other software solution for orthopedic care,” said Dr. James Reeves, of Town Center Orthopaedic Associates in Reston, VA. “As a surgeon, my top priorities are providing effective, empathetic patient care while achieving excellent surgical outcomes. Motion iQ allows me to fundamentally transform the way I engage with and empower my patients before and after surgery to optimize outcomes and patient satisfaction.”

As an early adopter, Dr. Reeves has more than 200 patients actively using Motion iQ, and patient feedback has been overwhelmingly positive. “Patients absolutely love the more personalized care I can provide with Motion iQ,” added Reeves.

More than 1.6 million total joint procedures are done annually, and that number is expected to reach 1.8 million by 2024.1 The mobile health technologies market is expected to reach a staggering $60 billion in size by 2023, with an estimated 5 million patients being monitored remotely,2 while remote monitoring is expected to save approximately $200 billion in health care costs over the next 25 years.3 Motion iQ™ is the intersection of orthopedics and digital healthcare, designed to streamline practice workflow and efficiency and help facilitate value-based care. “As a solution designed to increase patient satisfaction, compliance, and outcomes, Motion iQ can deliver increased productivity while decreasing clinic call volume, procedure cancellations, and readmissions,” notes Shirley.

Already at the forefront of connected orthopedic medicine, DJO plans to expand Motion iQ features and functionality with connected brace solutions.

For more information on Motion iQ, please visit: DJOglobal.com/MotioniQ.

About DJO®

DJO, a subsidiary of Colfax Corporation (NYSE: CFX), is a leading developer and distributor of high-quality medical devices that provide proven solutions for musculoskeletal health, joint reconstruction, vascular health, and pain management. The Company’s extensive range of products and integrated technologies address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative rehabilitation; enabling people around the world to regain or maintain their natural motion. For additional information about DJO, please visit www.DJOGlobal.com.

Dr. James Reeves is a paid consultant of DJO®.

SmartTRAK® is a registered trademark of BIOMEDGPS, LLC.

  1. SmartTRAK®. Total Joints-US Market Overview. 2020. https://app.smarttrak.com/markets/qs/6de8207f33a0d4feac1002a54495fef0
  2. https://www.juniperresearch.com/press/press-releases/healthcare-spend-in-wearables-reach-60-bn-2023
  3. https://www2.deloitte.com/content/dam/Deloitte/us/Documents/life-sciences-health-care/us-dchs-connected-health.pdf


© Business Wire 2020
03:26pCOLFAX : UBS Adjusts Price Target on Colfax to $45 From $40, Reiterates Buy Rati..
01/08INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Colfax
2020INSIDER TRENDS : 90-Day Insider Buying Trend at Colfax Interrupted with Sale of ..
2020COLFAX : Deutsche Bank Adjusts Price Target for Colfax to $39 From $36, Maintain..
2020COLFAX : Morgan Stanley Adjusts Colfax' Price Target to $39 from $30, Keeps Equa..
2020INSIDER TRENDS : Insider Purchase Continues Colfax Positive Trend
2020COLFAX : DJO, a Subsidiary of Colfax, Acquires LiteCure Laser Therapy for Undisc..
2020COLFAX : DJO® Acquires LiteCure Laser Therapy
2020Barclays Adjusts Colfax's Price Target to $35 From $31, Keeps Equal-Weight Ra..
2020KeyBanc Adjusts Colfax's Price Target to $44 From $36, Keeps at Overweight
More news
Financials (USD)
Sales 2020 3 070 M - -
Net income 2020 48,6 M - -
Net Debt 2020 2 099 M - -
P/E ratio 2020 102x
Yield 2020 -
Capitalization 4 588 M 4 588 M -
EV / Sales 2020 2,18x
EV / Sales 2021 1,91x
Nbr of Employees 15 000
Free-Float 84,9%
Duration : Period :
Colfax Corporation Technical Analysis Chart | CFX | US1940141062 | MarketScreener
Technical analysis trends COLFAX CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 18
Average target price 43,50 $
Last Close Price 38,73 $
Spread / Highest target 47,2%
Spread / Average Target 12,3%
Spread / Lowest Target -9,63%
EPS Revisions
Managers and Directors
Matthew L. Trerotola President, Chief Executive Officer & Director
Mitchell P. Rales Non-Executive Chairman
Christopher Michael Hix CFO, Treasurer & Senior Vice President
Patrick William Allender Independent Director
Thomas Sinnickson Gayner Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ATLAS COPCO AB10.19%64 937
SANDVIK AB8.30%32 880